Alzheimer Prevention Trials (APT) Webstudy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03638583|
Recruitment Status : Recruiting
First Posted : August 20, 2018
Last Update Posted : November 3, 2020
|Condition or disease|
|Alzheimer Disease Dementia|
The APT Webstudy will use web-based cognitive testing and questionnaires to generate a risk score which will be used to identify individuals who may be at an increased risk for developing AD dementia.
Individuals who join the APT Webstudy will register at https://www.aptwebstudy.org/, sign an electronic informed consent form (ICF), provide basic demographic information and participate in web-based cognitive testing. Participants will return the APT Webstudy quarterly (every 3 months) to complete the cognitive testing again.
Based on the risk score and changes identified in the cognitive testing results, participants will be invited to visit a partnering clinical trial site for an in-person visit with biomarker testing and clinical assessment.
The combined results of the web-based assessments, with the biomarker and clinical assessments, will allow an adaptive statistical algorithm to improve the selection of those at highest risk for developing AD.
To Join the APT Webstudy, please visit https://www.aptwebstudy.org/.
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||200000 participants|
|Target Follow-Up Duration:||5 Years|
|Official Title:||Alzheimer Prevention Trials (APT) Webstudy|
|Actual Study Start Date :||December 20, 2017|
|Estimated Primary Completion Date :||April 30, 2022|
|Estimated Study Completion Date :||April 30, 2022|
- Enrollment into Alzheimer's prevention research studies [ Time Frame: 5 years ]
- Referral into prevention research studies [ Time Frame: 5 years ]
- Number of individuals enrolled into Alzheimer's prevention studies [ Time Frame: 5 years ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03638583
|Contact: APT Webstudy Teamfirstname.lastname@example.org|
|United States, California|
|San Diego, California, United States, 92121|
|Contact: APT Webstudy Team 858-877-3135 email@example.com|
|Principal Investigator:||Paul Aisen, MD||USC ATRI|
|Principal Investigator:||Reisa Sperling, MD||Brigham and Women's Hospital|
|Principal Investigator:||Jeffrey Cummings, MD||The Cleveland Clinic|